Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sanaa Chala has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Alternative Strategies for Managing Dental Black Stains: A Systematic Review

    by Omaima Boukhancha, Manal Amimer, Sanaa Chala

    Background/Objectives: Dental black stains (BSs) are a form of extrinsic tooth discoloration of bacterial origin, with a prevalence ranging from 2.4% to 20%. As scaling and polishing remain the standard of care, recurrence is frequent. Therefore, this systematic review assessed alternative or adjunctive treatments, such as probiotics, chemical agents, and photodynamic therapy, for managing BSs. The primary objective was to evaluate clinical changes in BS recurrence and severity, while the secondary objective was to analyze microbiological changes. Methods: Conducted following PRISMA 2020 guidelines and registered on PROSPERO (CRD420261357137), this review searched PubMed, Cochrane Library, Scopus, Web of Science, and Dentistry & Oral Sciences Source through EBSCOhost as well as clinical trial registers (ClinicalTrials.gov and ISRCTN) and grey literature, up to 30 April 2026, with no language or date restrictions. We included randomized and non-randomized clinical trials. Two independent reviewers performed study selection and data extraction; a third resolved disagreements. We assessed risk of bias using RoB 2 and ROBINS-I V2, and quality of evidence using GRADE. Results: Of 716 records identified, eight clinical trials (five randomized clinical trials and three non-randomized clinical trials were included), with 250 patients enrolled and 227 assessed at follow-up. Four intervention categories were investigated: probiotics, antimicrobial mouthwashes (0.1%, 0.12% chlorhexidine and 0.1% chlorine dioxide), enzyme-containing toothpaste, and antimicrobial photodynamic therapy (aPDT). Probiotics may reduce BS indices, though the effect was inconsistent over time. In a single small, randomized study, chlorine dioxide showed a short-term reduction in bacterial viability greater than chlorhexidine. aPDT and enzyme-containing toothpaste did not show a significant benefit in the included studies. High risk of bias, heterogeneity, and the small sample prevented quantitative synthesis. Conclusions: Evidence supporting alternative strategies for managing recurrent dental BSs or reducing chromogenic bacterial load remains insufficient. Larger RCTs with standardized outcomes and longer follow-up are needed.

  • Open Access

    The Oral Bacteriome

    by Soukaina Ghaouas, Sanaa Chala

    The oral microbiome has garnered significant interest in recent years. Its profound implications for oral and systemic diseases have led to a considerable amount of research and analysis aimed at providing deeper insights into its composition. This study aimed to characterize oral bacterial communities comprehensively based on microorganisms indexed in the Human Oral Microbiome Database, which was systematically analyzed, and its taxonomic classification was used to describe the diversity of indexed bacteria in the oral cavity. A total of 522 bacteria were considered for the analysis. Among these, 49.04% were named, whereas 29.12% represent uncultivated phylotypes. The taxonomic characterization revealed that more than 80% of total taxa are distributed across five phyla: Bacillota, Bacteroidota, Actinomycetota, Pseudomonadota, and Fusobacteriota. Of these, Bacillota and Bacteroidota are the dominant ones with, respectively, 166 (31.80%) and 96 (18.39%) bacterial taxa. With the recent advances in genomics and bioinformatics, the HOMD is constantly updated, further enhancing our understanding of the bacterial community of the oral microbiome. However, the considerable diversity of the oral microbiome may present analytical challenges and the possible misperception of the implications of closely related species/subspecies in oral and systemic health.


  • Osteopontin as a prognostic biomarker in head and neck cancer– a systematic review and meta-analysis

    by Nadisha Piyarathne, Kalani Hettiarachchi, Monal Yuwanati, Gowri Sivaramakrishnan, Anand Ramanathan, Ruwan Jayasinghe, Sanaa Chala, Akhilanand Chaurasia

    Background Osteopontin (OPN) is linked to cancer progression, metastasis, and treatment resistance in head and neck cancer (HNC). This meta-analysis evaluated OPN as a prognostic biomarker in HNC. Method A comprehensive search was conducted for studies published up to December 2023, including English papers on HNC analyzing OPN expression. Data extraction, quality assessment, and quantitative analysis were performed using fixed and random effect models with 95% CI. Heterogeneity and publication bias were assessed with I2 and Egger’s regression test. Results Fifty-one studies were included. OPN expression was significantly elevated in tissue and plasma in HNC compared to control (SMD 0.98; 95% CI 0.47–1.49; I2 = 13%; p < 0.00). High plasma OPN predicted poor survival (HR: 2.00; I2 = 64%; P = 0.03), as did high tissue OPN (hazard ratio: 2.71, 95% confidence interval = 1.51–4.87; I2 = 49.4%, p > 0.05). Elevated plasma OPN correlated with smoking, poorly differentiated neoplasms, larger tumors, advanced stage, and lymph node metastasis. Positive tissue OPN was associated with nodal involvement, advanced stage, male gender, and smoking. Conclusion OPN is a robust prognostic biomarker in HNC, indicating tumor aggressiveness and poor prognostic outcomes. Standardized measurement protocols and further validation in prospective studies are necessary.


  • Open Access

    Core outcomes measures in dental computer vision studies (DentalCOMS)

    by Martha Büttner, Rata Rokhshad, Janet Brinz, Julien Issa, Akhilanand Chaurasia, Sergio E. Uribe, Teodora Karteva, Sanaa Chala, Antonin Tichy, Falk Schwendicke


  • Application of Genomic Medicine in Africa: 14th Conference of the African Society of Human Genetics and the 2nd International Congress of the Moroccan Society of Genomics and Human Genetics, Rabat, Morocco 2022

    by Meryem Fakhkhari, Ikram Salih, Najwa Maazaz, Victoria Nembaware, Nchangwi Syntia Munung, Alice Matimba, Sanaa Chala, Ahmed Belmouden, Karon Chappell, Leon Mutesa, et al.

    : The 14th African Society of Human Genetics (AfSHG) Morocco Meeting and 2nd International Congress of the Moroccan Society of Genomics and Human Genetics (SM2GH), held in Rabat, Morocco, from December 12 through 17, 2022, brought together 298 attendees from 23 countries, organized by the AfSHG in collaboration with the SM2GH. The conference’s overarching theme was “Applications of Genomics Medicine in Africa,” covering a wide range of topics, including population genetics, genetics of infectious diseases, hereditary disorders, cancer genetics, and translational genetics. The conference aimed to address the lag in the field of genetics in Africa and highlight the potential for genetic research and personalized medicine on the continent. The goal was to improve the health of African populations and global communities while nurturing the careers of young African scientists in the field. Distinguished scientists from around the world shared their recent findings in genetics, immunogenetics, genomics, genome editing, immunotherapy, and ethics genomics. Precongress activities included a 2-day bioinformatics workshop, “NGS Analysis for Monogenic Disease in African Populations,” and a Young Investigators Forum, providing opportunities for young African researchers to showcase their work. The vast genetic diversity of the African continent poses a significant challenge in investigating and characterizing public health issues at the genetic and functional levels. Training, research, and the development of expertise in genetics, immunology, genomics, and bioinformatics are vital for addressing these challenges and advancing genetics in Africa. The AfSHG is committed to leading efforts to enhance genetic research, coordinate training, and foster research collaborations on the continent.